Fred B Craves
CIK 1014095 · last filed 2025-03-14
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
MDGL price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
STE 600
SAN FRANCISCO, CA 94111
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MDGL | Director | 352,779 | $437.74 | $154.43M | -$220.59M | 26 | 2025-03-14 |
| TWST | Director | 58,168 | $145.25 | $8.45M | $0 | 2 | 2019-10-09 |
| DERM | Director | 9,000 | $4.97 | $44.7K | $1.80M | 8 | 2019-06-14 |
| PONIARD PHARMACEUTICALS, INC. (PARDD) Delisted | Director | 635,739 | — | — | $1.00M | 21 | 2011-06-10 |
| VIA Pharmaceuticals, Inc. (VIAP) Delisted | Director | — | — | — | $0 | 1 | 2009-03-16 |
Recent Filings · Page 6 of 7
70 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2009-06-25 | PONIARD PHARMACEUTICALS, INC. (PARDD) Delisted | Grant (A) | — | $0 | EDGAR |
| 2009-03-30 | PONIARD PHARMACEUTICALS, INC. (PARDD) Delisted | Buy (P) | +5,000 | $10.7K | EDGAR |
| 2009-03-30 | PONIARD PHARMACEUTICALS, INC. (PARDD) Delisted | Buy (P) | +15,000 | $31.5K | EDGAR |
| 2009-03-16 | VIA Pharmaceuticals, Inc. (VIAP) Delisted | Buy (P) | — | $0 | EDGAR |
| 2008-12-23 | PONIARD PHARMACEUTICALS, INC. (PARDD) Delisted | Buy (P) | +2,900 | $5.1K | EDGAR |
| 2008-12-23 | PONIARD PHARMACEUTICALS, INC. (PARDD) Delisted | Buy (P) | +25,000 | $43.8K | EDGAR |
| 2008-12-19 | PONIARD PHARMACEUTICALS, INC. (PARDD) Delisted | Buy (P) | +26,500 | $50.3K | EDGAR |
| 2008-12-17 | PONIARD PHARMACEUTICALS, INC. (PARDD) Delisted | Buy (P) | +13,000 | $24.9K | EDGAR |
| 2008-12-17 | PONIARD PHARMACEUTICALS, INC. (PARDD) Delisted | Buy (P) | +11,900 | $23.3K | EDGAR |
| 2008-06-25 | PONIARD PHARMACEUTICALS, INC. (PARDD) Delisted | Grant (A) | — | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.